14-22981788-T-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_032876.6(AJUBA):āc.479A>Gā(p.Asn160Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000717 in 1,534,178 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_032876.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AJUBA | NM_032876.6 | c.479A>G | p.Asn160Ser | missense_variant | 1/8 | ENST00000262713.7 | NP_116265.1 | |
AJUBA | NM_001289097.2 | c.479A>G | p.Asn160Ser | missense_variant | 1/2 | NP_001276026.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AJUBA | ENST00000262713.7 | c.479A>G | p.Asn160Ser | missense_variant | 1/8 | 1 | NM_032876.6 | ENSP00000262713 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152220Hom.: 1 Cov.: 33
GnomAD4 exome AF: 0.00000579 AC: 8AN: 1381958Hom.: 0 Cov.: 31 AF XY: 0.00000733 AC XY: 5AN XY: 681948
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152220Hom.: 1 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74366
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 09, 2021 | The c.479A>G (p.N160S) alteration is located in exon 1 (coding exon 1) of the AJUBA gene. This alteration results from a A to G substitution at nucleotide position 479, causing the asparagine (N) at amino acid position 160 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at